nodes	percent_of_prediction	percent_of_DWPC	metapath
Alendronate—PTPN4—brainstem—multiple sclerosis	0.0323	0.0717	CbGeAlD
Alendronate—PTPN4—retina—multiple sclerosis	0.0312	0.0692	CbGeAlD
Alendronate—PTPRS—brainstem—multiple sclerosis	0.0277	0.0615	CbGeAlD
Alendronate—PTPRE—midbrain—multiple sclerosis	0.0217	0.048	CbGeAlD
Alendronate—PTPRE—nervous system—multiple sclerosis	0.0178	0.0395	CbGeAlD
Alendronate—PTPRS—spinal cord—multiple sclerosis	0.0172	0.0382	CbGeAlD
Alendronate—PTPRE—central nervous system—multiple sclerosis	0.0172	0.038	CbGeAlD
Alendronate—PTPN4—nervous system—multiple sclerosis	0.0169	0.0376	CbGeAlD
Alendronate—PTPRE—cerebellum—multiple sclerosis	0.0168	0.0372	CbGeAlD
Alendronate—PTPN4—central nervous system—multiple sclerosis	0.0163	0.0362	CbGeAlD
Alendronate—ATP6V1A—brainstem—multiple sclerosis	0.016	0.0354	CbGeAlD
Alendronate—PTPN4—cerebellum—multiple sclerosis	0.0159	0.0354	CbGeAlD
Alendronate—ATP6V1A—retina—multiple sclerosis	0.0154	0.0342	CbGeAlD
Alendronate—PTPRS—nervous system—multiple sclerosis	0.0145	0.0322	CbGeAlD
Alendronate—PTPRS—central nervous system—multiple sclerosis	0.014	0.031	CbGeAlD
Alendronate—PTPRS—cerebellum—multiple sclerosis	0.0137	0.0303	CbGeAlD
Alendronate—PTPRE—brain—multiple sclerosis	0.0136	0.0302	CbGeAlD
Alendronate—PTPN4—brain—multiple sclerosis	0.013	0.0287	CbGeAlD
Alendronate—ATP6V1A—medulla oblongata—multiple sclerosis	0.0111	0.0247	CbGeAlD
Alendronate—PTPRS—brain—multiple sclerosis	0.0111	0.0246	CbGeAlD
Alendronate—ATP6V1A—midbrain—multiple sclerosis	0.0102	0.0226	CbGeAlD
Alendronate—ATP6V1A—spinal cord—multiple sclerosis	0.00994	0.022	CbGeAlD
Alendronate—FDPS—medulla oblongata—multiple sclerosis	0.0084	0.0186	CbGeAlD
Alendronate—ATP6V1A—nervous system—multiple sclerosis	0.00838	0.0186	CbGeAlD
Alendronate—ATP6V1A—central nervous system—multiple sclerosis	0.00806	0.0179	CbGeAlD
Alendronate—ATP6V1A—cerebellum—multiple sclerosis	0.00788	0.0175	CbGeAlD
Alendronate—FDPS—midbrain—multiple sclerosis	0.00767	0.017	CbGeAlD
Alendronate—FDPS—spinal cord—multiple sclerosis	0.00749	0.0166	CbGeAlD
Alendronate—ATP6V1A—brain—multiple sclerosis	0.0064	0.0142	CbGeAlD
Alendronate—FDPS—nervous system—multiple sclerosis	0.00631	0.014	CbGeAlD
Alendronate—FDPS—central nervous system—multiple sclerosis	0.00607	0.0135	CbGeAlD
Alendronate—FDPS—cerebellum—multiple sclerosis	0.00594	0.0132	CbGeAlD
Alendronate—FDPS—brain—multiple sclerosis	0.00482	0.0107	CbGeAlD
Alendronate—Alopecia—Mitoxantrone—multiple sclerosis	0.0018	0.00327	CcSEcCtD
Alendronate—Infection—Azathioprine—multiple sclerosis	0.00178	0.00323	CcSEcCtD
Alendronate—Erythema—Mitoxantrone—multiple sclerosis	0.00177	0.00323	CcSEcCtD
Alendronate—Urticaria—Cladribine—multiple sclerosis	0.00175	0.00318	CcSEcCtD
Alendronate—Abdominal pain—Cladribine—multiple sclerosis	0.00174	0.00317	CcSEcCtD
Alendronate—Body temperature increased—Cladribine—multiple sclerosis	0.00174	0.00317	CcSEcCtD
Alendronate—Dysgeusia—Mitoxantrone—multiple sclerosis	0.00173	0.00316	CcSEcCtD
Alendronate—Haemoglobin—Prednisolone—multiple sclerosis	0.00168	0.00306	CcSEcCtD
Alendronate—Haemorrhage—Prednisolone—multiple sclerosis	0.00167	0.00304	CcSEcCtD
Alendronate—Photosensitivity—Methotrexate—multiple sclerosis	0.00167	0.00304	CcSEcCtD
Alendronate—Ill-defined disorder—Mitoxantrone—multiple sclerosis	0.00164	0.00299	CcSEcCtD
Alendronate—Anaemia—Mitoxantrone—multiple sclerosis	0.00164	0.00298	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.00163	0.00297	CcSEcCtD
Alendronate—Hypersensitivity—Cladribine—multiple sclerosis	0.00162	0.00295	CcSEcCtD
Alendronate—Dry skin—Prednisone—multiple sclerosis	0.00161	0.00293	CcSEcCtD
Alendronate—Malaise—Mitoxantrone—multiple sclerosis	0.0016	0.00291	CcSEcCtD
Alendronate—Asthenia—Cladribine—multiple sclerosis	0.00158	0.00287	CcSEcCtD
Alendronate—Pruritus—Cladribine—multiple sclerosis	0.00156	0.00283	CcSEcCtD
Alendronate—Haemoglobin—Triamcinolone—multiple sclerosis	0.00154	0.00281	CcSEcCtD
Alendronate—Haemoglobin—Methylprednisolone—multiple sclerosis	0.00154	0.0028	CcSEcCtD
Alendronate—Haemorrhage—Triamcinolone—multiple sclerosis	0.00153	0.0028	CcSEcCtD
Alendronate—Haemorrhage—Methylprednisolone—multiple sclerosis	0.00153	0.00279	CcSEcCtD
Alendronate—Abdominal distension—Prednisone—multiple sclerosis	0.00152	0.00278	CcSEcCtD
Alendronate—Chest pain—Mitoxantrone—multiple sclerosis	0.00151	0.00275	CcSEcCtD
Alendronate—Myalgia—Mitoxantrone—multiple sclerosis	0.00151	0.00275	CcSEcCtD
Alendronate—Diarrhoea—Cladribine—multiple sclerosis	0.0015	0.00274	CcSEcCtD
Alendronate—Discomfort—Mitoxantrone—multiple sclerosis	0.00149	0.00271	CcSEcCtD
Alendronate—Feeling abnormal—Azathioprine—multiple sclerosis	0.00147	0.00268	CcSEcCtD
Alendronate—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.00146	0.00266	CcSEcCtD
Alendronate—Dizziness—Cladribine—multiple sclerosis	0.00145	0.00265	CcSEcCtD
Alendronate—Erythema—Prednisolone—multiple sclerosis	0.00145	0.00265	CcSEcCtD
Alendronate—Infection—Mitoxantrone—multiple sclerosis	0.00144	0.00262	CcSEcCtD
Alendronate—Abdominal pain—Azathioprine—multiple sclerosis	0.00141	0.00257	CcSEcCtD
Alendronate—Body temperature increased—Azathioprine—multiple sclerosis	0.00141	0.00257	CcSEcCtD
Alendronate—Haemoglobin—Dexamethasone—multiple sclerosis	0.0014	0.00255	CcSEcCtD
Alendronate—Haemoglobin—Betamethasone—multiple sclerosis	0.0014	0.00255	CcSEcCtD
Alendronate—Vomiting—Cladribine—multiple sclerosis	0.0014	0.00255	CcSEcCtD
Alendronate—Haemorrhage—Dexamethasone—multiple sclerosis	0.00139	0.00254	CcSEcCtD
Alendronate—Haemorrhage—Betamethasone—multiple sclerosis	0.00139	0.00254	CcSEcCtD
Alendronate—Rash—Cladribine—multiple sclerosis	0.00139	0.00253	CcSEcCtD
Alendronate—Dermatitis—Cladribine—multiple sclerosis	0.00138	0.00252	CcSEcCtD
Alendronate—Headache—Cladribine—multiple sclerosis	0.00138	0.00251	CcSEcCtD
Alendronate—Ill-defined disorder—Prednisolone—multiple sclerosis	0.00135	0.00246	CcSEcCtD
Alendronate—Erythema—Triamcinolone—multiple sclerosis	0.00134	0.00243	CcSEcCtD
Alendronate—Erythema—Methylprednisolone—multiple sclerosis	0.00133	0.00243	CcSEcCtD
Alendronate—Angioedema—Prednisolone—multiple sclerosis	0.00133	0.00242	CcSEcCtD
Alendronate—Toxic epidermal necrolysis—Methotrexate—multiple sclerosis	0.00132	0.0024	CcSEcCtD
Alendronate—Hypersensitivity—Azathioprine—multiple sclerosis	0.00132	0.0024	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.00132	0.0024	CcSEcCtD
Alendronate—Malaise—Prednisolone—multiple sclerosis	0.00131	0.00239	CcSEcCtD
Alendronate—Dysgeusia—Triamcinolone—multiple sclerosis	0.00131	0.00238	CcSEcCtD
Alendronate—Nausea—Cladribine—multiple sclerosis	0.00131	0.00238	CcSEcCtD
Alendronate—Vertigo—Prednisolone—multiple sclerosis	0.0013	0.00238	CcSEcCtD
Alendronate—Dyspepsia—Mitoxantrone—multiple sclerosis	0.00127	0.00232	CcSEcCtD
Alendronate—Asthma—Methotrexate—multiple sclerosis	0.00127	0.00231	CcSEcCtD
Alendronate—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.00124	0.00226	CcSEcCtD
Alendronate—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.00124	0.00225	CcSEcCtD
Alendronate—Pain—Mitoxantrone—multiple sclerosis	0.00124	0.00225	CcSEcCtD
Alendronate—Constipation—Mitoxantrone—multiple sclerosis	0.00124	0.00225	CcSEcCtD
Alendronate—Alopecia—Betamethasone—multiple sclerosis	0.00123	0.00224	CcSEcCtD
Alendronate—Alopecia—Dexamethasone—multiple sclerosis	0.00123	0.00224	CcSEcCtD
Alendronate—Diarrhoea—Azathioprine—multiple sclerosis	0.00122	0.00223	CcSEcCtD
Alendronate—Discomfort—Prednisolone—multiple sclerosis	0.00122	0.00223	CcSEcCtD
Alendronate—Angioedema—Triamcinolone—multiple sclerosis	0.00122	0.00222	CcSEcCtD
Alendronate—Haemoglobin—Prednisone—multiple sclerosis	0.00122	0.00222	CcSEcCtD
Alendronate—Angioedema—Methylprednisolone—multiple sclerosis	0.00122	0.00222	CcSEcCtD
Alendronate—Abdominal discomfort—Methotrexate—multiple sclerosis	0.00121	0.00221	CcSEcCtD
Alendronate—Haemorrhage—Prednisone—multiple sclerosis	0.00121	0.00221	CcSEcCtD
Alendronate—Erythema—Betamethasone—multiple sclerosis	0.00121	0.00221	CcSEcCtD
Alendronate—Erythema—Dexamethasone—multiple sclerosis	0.00121	0.00221	CcSEcCtD
Alendronate—Malaise—Triamcinolone—multiple sclerosis	0.0012	0.00219	CcSEcCtD
Alendronate—Malaise—Methylprednisolone—multiple sclerosis	0.0012	0.00219	CcSEcCtD
Alendronate—Vertigo—Triamcinolone—multiple sclerosis	0.0012	0.00219	CcSEcCtD
Alendronate—Vertigo—Methylprednisolone—multiple sclerosis	0.0012	0.00218	CcSEcCtD
Alendronate—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.00119	0.00217	CcSEcCtD
Alendronate—Dizziness—Azathioprine—multiple sclerosis	0.00118	0.00215	CcSEcCtD
Alendronate—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.00118	0.00215	CcSEcCtD
Alendronate—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.00116	0.00211	CcSEcCtD
Alendronate—Urticaria—Mitoxantrone—multiple sclerosis	0.00115	0.00209	CcSEcCtD
Alendronate—Abdominal pain—Mitoxantrone—multiple sclerosis	0.00114	0.00208	CcSEcCtD
Alendronate—Body temperature increased—Mitoxantrone—multiple sclerosis	0.00114	0.00208	CcSEcCtD
Alendronate—Myalgia—Triamcinolone—multiple sclerosis	0.00114	0.00207	CcSEcCtD
Alendronate—Vomiting—Azathioprine—multiple sclerosis	0.00114	0.00207	CcSEcCtD
Alendronate—Myalgia—Methylprednisolone—multiple sclerosis	0.00113	0.00207	CcSEcCtD
Alendronate—Rash—Azathioprine—multiple sclerosis	0.00113	0.00205	CcSEcCtD
Alendronate—Dermatitis—Azathioprine—multiple sclerosis	0.00113	0.00205	CcSEcCtD
Alendronate—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.00112	0.00205	CcSEcCtD
Alendronate—Ill-defined disorder—Betamethasone—multiple sclerosis	0.00112	0.00205	CcSEcCtD
Alendronate—Discomfort—Triamcinolone—multiple sclerosis	0.00112	0.00205	CcSEcCtD
Alendronate—Discomfort—Methylprednisolone—multiple sclerosis	0.00112	0.00204	CcSEcCtD
Alendronate—Headache—Azathioprine—multiple sclerosis	0.00112	0.00204	CcSEcCtD
Alendronate—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.00112	0.00204	CcSEcCtD
Alendronate—Angioedema—Dexamethasone—multiple sclerosis	0.00111	0.00202	CcSEcCtD
Alendronate—Angioedema—Betamethasone—multiple sclerosis	0.00111	0.00202	CcSEcCtD
Alendronate—Stomatitis—Methotrexate—multiple sclerosis	0.0011	0.002	CcSEcCtD
Alendronate—Malaise—Dexamethasone—multiple sclerosis	0.00109	0.00199	CcSEcCtD
Alendronate—Malaise—Betamethasone—multiple sclerosis	0.00109	0.00199	CcSEcCtD
Alendronate—Vertigo—Betamethasone—multiple sclerosis	0.00109	0.00198	CcSEcCtD
Alendronate—Vertigo—Dexamethasone—multiple sclerosis	0.00109	0.00198	CcSEcCtD
Alendronate—Infection—Triamcinolone—multiple sclerosis	0.00108	0.00197	CcSEcCtD
Alendronate—Infection—Methylprednisolone—multiple sclerosis	0.00108	0.00197	CcSEcCtD
Alendronate—Alopecia—Prednisone—multiple sclerosis	0.00107	0.00195	CcSEcCtD
Alendronate—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00106	0.00194	CcSEcCtD
Alendronate—Nausea—Azathioprine—multiple sclerosis	0.00106	0.00193	CcSEcCtD
Alendronate—Erythema—Prednisone—multiple sclerosis	0.00106	0.00192	CcSEcCtD
Alendronate—Asthenia—Mitoxantrone—multiple sclerosis	0.00104	0.00189	CcSEcCtD
Alendronate—Myalgia—Dexamethasone—multiple sclerosis	0.00103	0.00188	CcSEcCtD
Alendronate—Myalgia—Betamethasone—multiple sclerosis	0.00103	0.00188	CcSEcCtD
Alendronate—Discomfort—Dexamethasone—multiple sclerosis	0.00102	0.00186	CcSEcCtD
Alendronate—Discomfort—Betamethasone—multiple sclerosis	0.00102	0.00186	CcSEcCtD
Alendronate—Haemoglobin—Methotrexate—multiple sclerosis	0.00102	0.00186	CcSEcCtD
Alendronate—Pain—Prednisolone—multiple sclerosis	0.00101	0.00185	CcSEcCtD
Alendronate—Haemorrhage—Methotrexate—multiple sclerosis	0.00101	0.00185	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000993	0.00181	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000991	0.00181	CcSEcCtD
Alendronate—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000989	0.0018	CcSEcCtD
Alendronate—Infection—Betamethasone—multiple sclerosis	0.000983	0.00179	CcSEcCtD
Alendronate—Infection—Dexamethasone—multiple sclerosis	0.000983	0.00179	CcSEcCtD
Alendronate—Ill-defined disorder—Prednisone—multiple sclerosis	0.000979	0.00178	CcSEcCtD
Alendronate—Feeling abnormal—Prednisolone—multiple sclerosis	0.000977	0.00178	CcSEcCtD
Alendronate—Anaemia—Prednisone—multiple sclerosis	0.000975	0.00178	CcSEcCtD
Alendronate—Angioedema—Prednisone—multiple sclerosis	0.000964	0.00176	CcSEcCtD
Alendronate—Dyspepsia—Triamcinolone—multiple sclerosis	0.00096	0.00175	CcSEcCtD
Alendronate—Erythema multiforme—Methotrexate—multiple sclerosis	0.000958	0.00175	CcSEcCtD
Alendronate—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000957	0.00174	CcSEcCtD
Alendronate—Malaise—Prednisone—multiple sclerosis	0.000952	0.00173	CcSEcCtD
Alendronate—Vertigo—Prednisone—multiple sclerosis	0.000948	0.00173	CcSEcCtD
Alendronate—Urticaria—Prednisolone—multiple sclerosis	0.000942	0.00172	CcSEcCtD
Alendronate—Pain—Triamcinolone—multiple sclerosis	0.000932	0.0017	CcSEcCtD
Alendronate—Vomiting—Mitoxantrone—multiple sclerosis	0.000919	0.00167	CcSEcCtD
Alendronate—Rash—Mitoxantrone—multiple sclerosis	0.000911	0.00166	CcSEcCtD
Alendronate—Dermatitis—Mitoxantrone—multiple sclerosis	0.00091	0.00166	CcSEcCtD
Alendronate—Headache—Mitoxantrone—multiple sclerosis	0.000905	0.00165	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000901	0.00164	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000901	0.00164	CcSEcCtD
Alendronate—Myalgia—Prednisone—multiple sclerosis	0.000899	0.00164	CcSEcCtD
Alendronate—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000898	0.00164	CcSEcCtD
Alendronate—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000896	0.00163	CcSEcCtD
Alendronate—Alopecia—Methotrexate—multiple sclerosis	0.000895	0.00163	CcSEcCtD
Alendronate—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000889	0.00162	CcSEcCtD
Alendronate—Discomfort—Prednisone—multiple sclerosis	0.000888	0.00162	CcSEcCtD
Alendronate—Erythema—Methotrexate—multiple sclerosis	0.000882	0.00161	CcSEcCtD
Alendronate—Hypersensitivity—Prednisolone—multiple sclerosis	0.000873	0.00159	CcSEcCtD
Alendronate—Dyspepsia—Dexamethasone—multiple sclerosis	0.000871	0.00159	CcSEcCtD
Alendronate—Dyspepsia—Betamethasone—multiple sclerosis	0.000871	0.00159	CcSEcCtD
Alendronate—Urticaria—Triamcinolone—multiple sclerosis	0.000866	0.00158	CcSEcCtD
Alendronate—Urticaria—Methylprednisolone—multiple sclerosis	0.000864	0.00157	CcSEcCtD
Alendronate—Dysgeusia—Methotrexate—multiple sclerosis	0.000864	0.00157	CcSEcCtD
Alendronate—Body temperature increased—Triamcinolone—multiple sclerosis	0.000862	0.00157	CcSEcCtD
Alendronate—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00086	0.00157	CcSEcCtD
Alendronate—Nausea—Mitoxantrone—multiple sclerosis	0.000858	0.00156	CcSEcCtD
Alendronate—Infection—Prednisone—multiple sclerosis	0.000856	0.00156	CcSEcCtD
Alendronate—Pain—Dexamethasone—multiple sclerosis	0.000846	0.00154	CcSEcCtD
Alendronate—Pain—Betamethasone—multiple sclerosis	0.000846	0.00154	CcSEcCtD
Alendronate—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000818	0.00149	CcSEcCtD
Alendronate—Anaemia—Methotrexate—multiple sclerosis	0.000815	0.00149	CcSEcCtD
Alendronate—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000815	0.00148	CcSEcCtD
Alendronate—Feeling abnormal—Betamethasone—multiple sclerosis	0.000815	0.00148	CcSEcCtD
Alendronate—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000809	0.00147	CcSEcCtD
Alendronate—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000809	0.00147	CcSEcCtD
Alendronate—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000803	0.00146	CcSEcCtD
Alendronate—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000801	0.00146	CcSEcCtD
Alendronate—Malaise—Methotrexate—multiple sclerosis	0.000795	0.00145	CcSEcCtD
Alendronate—Vertigo—Methotrexate—multiple sclerosis	0.000792	0.00144	CcSEcCtD
Alendronate—Urticaria—Betamethasone—multiple sclerosis	0.000786	0.00143	CcSEcCtD
Alendronate—Urticaria—Dexamethasone—multiple sclerosis	0.000786	0.00143	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000785	0.00143	CcSEcCtD
Alendronate—Dizziness—Prednisolone—multiple sclerosis	0.000784	0.00143	CcSEcCtD
Alendronate—Asthenia—Triamcinolone—multiple sclerosis	0.000782	0.00142	CcSEcCtD
Alendronate—Body temperature increased—Betamethasone—multiple sclerosis	0.000782	0.00142	CcSEcCtD
Alendronate—Abdominal pain—Dexamethasone—multiple sclerosis	0.000782	0.00142	CcSEcCtD
Alendronate—Abdominal pain—Betamethasone—multiple sclerosis	0.000782	0.00142	CcSEcCtD
Alendronate—Body temperature increased—Dexamethasone—multiple sclerosis	0.000782	0.00142	CcSEcCtD
Alendronate—Asthenia—Methylprednisolone—multiple sclerosis	0.00078	0.00142	CcSEcCtD
Alendronate—Pruritus—Triamcinolone—multiple sclerosis	0.000771	0.00141	CcSEcCtD
Alendronate—Pruritus—Methylprednisolone—multiple sclerosis	0.00077	0.0014	CcSEcCtD
Alendronate—Dyspepsia—Prednisone—multiple sclerosis	0.000758	0.00138	CcSEcCtD
Alendronate—Myalgia—Methotrexate—multiple sclerosis	0.000751	0.00137	CcSEcCtD
Alendronate—Chest pain—Methotrexate—multiple sclerosis	0.000751	0.00137	CcSEcCtD
Alendronate—Rash—Prednisolone—multiple sclerosis	0.000747	0.00136	CcSEcCtD
Alendronate—Dermatitis—Prednisolone—multiple sclerosis	0.000747	0.00136	CcSEcCtD
Alendronate—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000744	0.00136	CcSEcCtD
Alendronate—Headache—Prednisolone—multiple sclerosis	0.000743	0.00135	CcSEcCtD
Alendronate—Discomfort—Methotrexate—multiple sclerosis	0.000742	0.00135	CcSEcCtD
Alendronate—Constipation—Prednisone—multiple sclerosis	0.000737	0.00134	CcSEcCtD
Alendronate—Dizziness—Triamcinolone—multiple sclerosis	0.000721	0.00131	CcSEcCtD
Alendronate—Dizziness—Methylprednisolone—multiple sclerosis	0.000719	0.00131	CcSEcCtD
Alendronate—Infection—Methotrexate—multiple sclerosis	0.000715	0.0013	CcSEcCtD
Alendronate—Feeling abnormal—Prednisone—multiple sclerosis	0.00071	0.00129	CcSEcCtD
Alendronate—Asthenia—Dexamethasone—multiple sclerosis	0.00071	0.00129	CcSEcCtD
Alendronate—Asthenia—Betamethasone—multiple sclerosis	0.00071	0.00129	CcSEcCtD
Alendronate—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000704	0.00128	CcSEcCtD
Alendronate—Nausea—Prednisolone—multiple sclerosis	0.000704	0.00128	CcSEcCtD
Alendronate—Pruritus—Betamethasone—multiple sclerosis	0.0007	0.00127	CcSEcCtD
Alendronate—Pruritus—Dexamethasone—multiple sclerosis	0.0007	0.00127	CcSEcCtD
Alendronate—Vomiting—Triamcinolone—multiple sclerosis	0.000693	0.00126	CcSEcCtD
Alendronate—Vomiting—Methylprednisolone—multiple sclerosis	0.000692	0.00126	CcSEcCtD
Alendronate—Rash—Triamcinolone—multiple sclerosis	0.000687	0.00125	CcSEcCtD
Alendronate—Dermatitis—Triamcinolone—multiple sclerosis	0.000687	0.00125	CcSEcCtD
Alendronate—Rash—Methylprednisolone—multiple sclerosis	0.000686	0.00125	CcSEcCtD
Alendronate—Dermatitis—Methylprednisolone—multiple sclerosis	0.000685	0.00125	CcSEcCtD
Alendronate—Urticaria—Prednisone—multiple sclerosis	0.000684	0.00125	CcSEcCtD
Alendronate—Headache—Triamcinolone—multiple sclerosis	0.000683	0.00124	CcSEcCtD
Alendronate—Headache—Methylprednisolone—multiple sclerosis	0.000681	0.00124	CcSEcCtD
Alendronate—Body temperature increased—Prednisone—multiple sclerosis	0.000681	0.00124	CcSEcCtD
Alendronate—Abdominal pain—Prednisone—multiple sclerosis	0.000681	0.00124	CcSEcCtD
Alendronate—Diarrhoea—Betamethasone—multiple sclerosis	0.000677	0.00123	CcSEcCtD
Alendronate—Diarrhoea—Dexamethasone—multiple sclerosis	0.000677	0.00123	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000656	0.00119	CcSEcCtD
Alendronate—Dizziness—Betamethasone—multiple sclerosis	0.000654	0.00119	CcSEcCtD
Alendronate—Dizziness—Dexamethasone—multiple sclerosis	0.000654	0.00119	CcSEcCtD
Alendronate—Nausea—Triamcinolone—multiple sclerosis	0.000647	0.00118	CcSEcCtD
Alendronate—Nausea—Methylprednisolone—multiple sclerosis	0.000646	0.00118	CcSEcCtD
Alendronate—Hypersensitivity—Prednisone—multiple sclerosis	0.000635	0.00116	CcSEcCtD
Alendronate—Dyspepsia—Methotrexate—multiple sclerosis	0.000634	0.00115	CcSEcCtD
Alendronate—Vomiting—Dexamethasone—multiple sclerosis	0.000629	0.00115	CcSEcCtD
Alendronate—Vomiting—Betamethasone—multiple sclerosis	0.000629	0.00115	CcSEcCtD
Alendronate—Rash—Betamethasone—multiple sclerosis	0.000624	0.00114	CcSEcCtD
Alendronate—Rash—Dexamethasone—multiple sclerosis	0.000624	0.00114	CcSEcCtD
Alendronate—Dermatitis—Betamethasone—multiple sclerosis	0.000623	0.00114	CcSEcCtD
Alendronate—Dermatitis—Dexamethasone—multiple sclerosis	0.000623	0.00114	CcSEcCtD
Alendronate—Headache—Dexamethasone—multiple sclerosis	0.00062	0.00113	CcSEcCtD
Alendronate—Headache—Betamethasone—multiple sclerosis	0.00062	0.00113	CcSEcCtD
Alendronate—Asthenia—Prednisone—multiple sclerosis	0.000618	0.00113	CcSEcCtD
Alendronate—Pain—Methotrexate—multiple sclerosis	0.000616	0.00112	CcSEcCtD
Alendronate—Pruritus—Prednisone—multiple sclerosis	0.000609	0.00111	CcSEcCtD
Alendronate—Feeling abnormal—Methotrexate—multiple sclerosis	0.000593	0.00108	CcSEcCtD
Alendronate—Diarrhoea—Prednisone—multiple sclerosis	0.000589	0.00107	CcSEcCtD
Alendronate—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000589	0.00107	CcSEcCtD
Alendronate—Nausea—Betamethasone—multiple sclerosis	0.000587	0.00107	CcSEcCtD
Alendronate—Nausea—Dexamethasone—multiple sclerosis	0.000587	0.00107	CcSEcCtD
Alendronate—Urticaria—Methotrexate—multiple sclerosis	0.000572	0.00104	CcSEcCtD
Alendronate—Dizziness—Prednisone—multiple sclerosis	0.00057	0.00104	CcSEcCtD
Alendronate—Abdominal pain—Methotrexate—multiple sclerosis	0.000569	0.00104	CcSEcCtD
Alendronate—Body temperature increased—Methotrexate—multiple sclerosis	0.000569	0.00104	CcSEcCtD
Alendronate—Vomiting—Prednisone—multiple sclerosis	0.000548	0.000998	CcSEcCtD
Alendronate—Rash—Prednisone—multiple sclerosis	0.000543	0.000989	CcSEcCtD
Alendronate—Dermatitis—Prednisone—multiple sclerosis	0.000543	0.000989	CcSEcCtD
Alendronate—Headache—Prednisone—multiple sclerosis	0.00054	0.000983	CcSEcCtD
Alendronate—Hypersensitivity—Methotrexate—multiple sclerosis	0.00053	0.000966	CcSEcCtD
Alendronate—Asthenia—Methotrexate—multiple sclerosis	0.000516	0.000941	CcSEcCtD
Alendronate—Nausea—Prednisone—multiple sclerosis	0.000512	0.000932	CcSEcCtD
Alendronate—Pruritus—Methotrexate—multiple sclerosis	0.000509	0.000928	CcSEcCtD
Alendronate—Diarrhoea—Methotrexate—multiple sclerosis	0.000493	0.000897	CcSEcCtD
Alendronate—Dizziness—Methotrexate—multiple sclerosis	0.000476	0.000867	CcSEcCtD
Alendronate—Vomiting—Methotrexate—multiple sclerosis	0.000458	0.000834	CcSEcCtD
Alendronate—Rash—Methotrexate—multiple sclerosis	0.000454	0.000827	CcSEcCtD
Alendronate—Dermatitis—Methotrexate—multiple sclerosis	0.000453	0.000826	CcSEcCtD
Alendronate—Headache—Methotrexate—multiple sclerosis	0.000451	0.000822	CcSEcCtD
Alendronate—Nausea—Methotrexate—multiple sclerosis	0.000428	0.000779	CcSEcCtD
